nach oben

Digestive Diseases and Sciences

Erschienen in:

04.10.2019 | Original Article

A20 Restores Impaired Intestinal Permeability and Inhibits Th2 Response in Mice with Colitis

verfasst von: Donghui Chen, Li Ma, Tianyong Hu, Jiangqi Liu, Baohui Chen, Pingchang Yang, Zhiqiang Liu

Erschienen in: Digestive Diseases and Sciences | Ausgabe 5/2020

Einloggen, um Zugang zu erhalten

Abstract

Background/Aims

The etiology of inflammatory bowel disease is multifactorial and still obscure. The protective role of ubiquitin E3 ligase A20 (A20) in colitis needs to be further elucidated. This study aimed to investigate whether A20 exogenous administration restored impaired intestinal permeability and inhibited T helper (Th)2 response in mice with colitis.

Methods

The effect of A20 overexpression in colonic mucosa on epithelial barrier function and T cell differentiation was evaluated in mice with dextran sulfate sodium (DSS)-induced chronic colitis.

Results

A20 rectal treatment alleviated DSS-induced chronic colitis and restored impaired intestinal permeability. Oral challenge with 2% DSS elicited a Th2-type response in mice with colitis, and A20 rectal treatment inhibited CD4⁺ interleukin (IL)-4⁺ T cell differentiation and proliferation. In addition, the RNA expressions of Th2-related costimulatory molecular T-cell immunoglobulin and mucin domain (TIM)-1 and IL-4 were suppressed, while thrombospondin (TSP)-1 and interferon (IFN)-γ expressions were upregulated, after A20 rectal administration.

Conclusion

A20 rectal treatment restores impaired intestinal permeability and inhibits activated Th2 cell response in mice with colitis.

Dolan KT, Chang EB. Diet, gut microbes, and the pathogenesis of inflammatory bowel diseases. Mol Nutr Food Res. 2017. https://doi.org/10.1002/mnfr.201600129.CrossRefPubMed

Geremia A, Biancheri P, Allan P, et al. Innate and adaptive immunity in inflammatory bowel disease. Autoimmun Rev. 2014;13:3–10. https://doi.org/10.1016/j.autrev.2013.06.004.CrossRefPubMed

Ahmad R, Sorrell MF, Batra SK, et al. Gut permeability and mucosal inflammation: bad, good or context dependent. Mucosal Immunol. 2017;10:307–317. https://doi.org/10.1038/mi.2016.128.CrossRefPubMedPubMedCentral

Zhang M, Peng LL, Wang Y, et al. Roles of A20 in autoimmune diseases. Immunol Res. 2016;64:337–344. https://doi.org/10.1007/s12026-015-8677-6.CrossRefPubMed

Ma A, Malynn BA. A20: linking a complex regulator of ubiquitylation to immunity and human disease. Nat Rev Immunol. 2012;12:774–785. https://doi.org/10.1038/nri3313.CrossRefPubMedPubMedCentral

Buzza MS, Johnson TA, Conway GD, et al. Inflammatory cytokines down-regulate the barrier-protective prostasin-matriptase proteolytic cascade early in experimental colitis. J Biol Chem. 2017;292:10801–10812. https://doi.org/10.1074/jbc.M116.771469.CrossRefPubMedPubMedCentral

Chen ML, Sundrud MS. Cytokine networks and T-cell subsets in inflammatory bowel diseases. Inflamm Bowel Dis. 2016;22:1157–1167. https://doi.org/10.1097/mib.0000000000000714.CrossRefPubMedPubMedCentral

Heller F, Florian P, Bojarski C, et al. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology. 2005;129:550–564. https://doi.org/10.1016/j.gastro.2005.05.002.CrossRefPubMed

Hammer GE, Turer EE, Taylor KE, et al. Expression of A20 by dendritic cells preserves immune homeostasis and prevents colitis and spondyloarthritis. Nat Immunol. 2011;12:1184–1193. https://doi.org/10.1038/ni.2135.CrossRefPubMedPubMedCentral

10.

Hu T, Hu W, Ma L, et al. pVAX1-A20 alleviates colitis in mice by promoting regulatory T cells. Dig Liver Dis Official J Ital Soc Gastroenterol Ital Assoc Study Liver. 2018. https://doi.org/10.1016/j.dld.2018.11.005.CrossRef

11.

Samtiya M, Bhat MI, Gupta T et al. Safety assessment of potential probiotic lactobacillus fermentum MTCC-5898 in murine model after repetitive dose for 28 days (sub-acute exposure). 2019. https://doi.org/10.1007/s12602-019-09529-6.

12.

Wu X, Yang Y, Dou Y, et al. Arctigenin but not arctiin acts as the major effective constituent of Arctium lappa L. fruit for attenuating colonic inflammatory response induced by dextran sulfate sodium in mice. Int Immunopharmacol. 2014;23:505–515. https://doi.org/10.1016/j.intimp.2014.09.026.CrossRefPubMed

13.

Feng BS, Chen X, He SH, et al. Disruption of T-cell immunoglobulin and mucin domain molecule (TIM)-1/TIM4 interaction as a therapeutic strategy in a dendritic cell-induced peanut allergy model. J Allerg Clin Immunol. 2008;122:55–61. https://doi.org/10.1016/j.jaci.2008.04.036.CrossRef

14.

Yang G, Geng XR, Liu ZQ, et al. Thrombospondin-1 (TSP1)-producing B cells restore antigen (Ag)-specific immune tolerance in an allergic environment. J Biol Chem. 2015;290:12858–12867. https://doi.org/10.1074/jbc.M114.623421.CrossRefPubMedPubMedCentral

15.

Vereecke L, Sze M, Mc Guire C, et al. Enterocyte-specific A20 deficiency sensitizes to tumor necrosis factor-induced toxicity and experimental colitis. J Exp Med. 2010;207:1513–1523. https://doi.org/10.1084/jem.20092474.CrossRefPubMedPubMedCentral

16.

Michielan A, D’Inca R. Intestinal permeability in inflammatory bowel disease: pathogenesis, clinical evaluation, and therapy of leaky gut. Mediat Inflamm. 2015;2015:628157. https://doi.org/10.1155/2015/628157.CrossRef

17.

Kolodziej LE, Lodolce JP, Chang JE, et al. TNFAIP3 maintains intestinal barrier function and supports epithelial cell tight junctions. PloS One. 2011;6:e26352. https://doi.org/10.1371/journal.pone.0026352.CrossRefPubMedPubMedCentral

18.

Wang J, Ouyang Y, Guner Y, et al. Ubiquitin-editing enzyme A20 promotes tolerance to lipopolysaccharide in enterocytes. J Immunol (Baltimore, Md: 1950). 2009;183:1384–1392. https://doi.org/10.4049/jimmunol.0803987.CrossRef

19.

Garcia-Carbonell R, Wong J, Kim JY, et al. Elevated A20 promotes TNF-induced and RIPK1-dependent intestinal epithelial cell death. Proc Natl Acad Sci U S A. 2018;115:E9192-e200. https://doi.org/10.1073/pnas.1810584115.CrossRef

20.

Wirtz S, Popp V, Kindermann M, et al. Chemically induced mouse models of acute and chronic intestinal inflammation. Nat Protoc. 2017;12:1295–1309. https://doi.org/10.1038/nprot.2017.044.CrossRefPubMed

21.

Kang NI, Yoon HY, Lee YR, et al. A20 attenuates allergic airway inflammation in mice. J Immunol (Baltimore, Md : 1950). 2009;183:1488–1495. https://doi.org/10.4049/jimmunol.0900163.CrossRef

Titel: A20 Restores Impaired Intestinal Permeability and Inhibits Th2 Response in Mice with Colitis
verfasst von: Donghui Chen
Li Ma
Tianyong Hu
Jiangqi Liu
Baohui Chen
Pingchang Yang
Zhiqiang Liu
Publikationsdatum: 04.10.2019
Verlag: Springer US
Erschienen in: Digestive Diseases and Sciences / Ausgabe 5/2020
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI: https://doi.org/10.1007/s10620-019-05860-8

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

19.04.2024 | Vorhofflimmern | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

A20 Restores Impaired Intestinal Permeability and Inhibits Th2 Response in Mice with Colitis

Abstract

Background/Aims

Methods

Results

Conclusion

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Denken Sie bei starker Blutung auch an die Hemmkörper-Hämophilie

Update Innere Medizin

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Background/Aims

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2020

LncRNA E2F-Mediated Cell Proliferation Enhancing lncRNA Regulates Cancer Cell Behaviors and Affects Prognosis of Gastric Cancer

Sending in the ViCE Squad: Evaluation and Management of Patients with Small Intestinal Bleeding

Ustekinumab Serum Trough Levels May Identify Suboptimal Responders to Ustekinumab in Crohn’s Disease

Patients with Alcoholic Liver Disease Have Worse Functional Status at Time of Liver Transplant Registration and Greater Waitlist and Post-transplant Mortality Which Is Compounded by Older Age

Botulinum Toxin A Improves Symptoms of Gastroparesis

Noninvasive Measurements Predict Liver Fibrosis Well in Hepatitis C Virus Patients After Direct-Acting Antiviral Therapy

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Denken Sie bei starker Blutung auch an die Hemmkörper-Hämophilie

Update Innere Medizin